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Abstract : Osteoarthritis is a complicated clinical condition affected by age, 
mechanical stress, cartilage hypertrophy, cytokines, and genetic predisposition.  In 
this study, we compared the effects of various anti-inflammatory analgesics on 
mechanical stress-induced inflammation in a synovial sarcoma cell line （SW982 
cells）.  SW982 cells exposed to mechanical stress by shaking with hydroxyapatite-
simulating bone chips were treated with acetaminophen, ketoprofen, triamcinolone 
acetonide, celecoxib, or neurotrophin for 48 hr.  The expression of integrin α5β1  
receptor, observed in fibroblasts and synovium, was evaluated.  Levels of the 
transcription factor, nuclear factor-κB, the inflammatory cytokine, tumor necrosis 
factor-α, the proteolytic enzyme, matrix metalloproteinase-3, and prostaglandin 
E2, which is associated with pain and arachidonate cascade product levels, were 
measured by ELISA.  The expression of integrin α5β1 was signiﬁcantly increased 
by mechanical stress.  Activation of nuclear factor-κB by mechanical stress was 
signiﬁcantly suppressed by celecoxib only.  Mechanical stress-induced increases in 
tumor necrosis factor-α and matrix metalloproteinase-3 levels were significantly 
suppressed by acetaminophen, triamcinolone acetonide, and neurotrophin.  The 
mechanical stress-induced increase in prostaglandin E2 levels was significantly 
suppressed by acetaminophen, ketoprofen, and celecoxib.  SW982 exposed to 
mechanical stress is proposed as a model for arthritis, and indeed, the expression 
of integrin α5β1, a membrane receptor protein that binds to fibronectin and 
the extracellular matrix, and is involved in cell proliferation, differentiation, and 
neovascularization in osteoarthritis, was significantly upregulated.  Following 
evaluation using this model, acetaminophen was found to possess anti-inﬂammatory, 
analgesic, and joint-destruction suppression properties.  This drug may, therefore, 
have applications in the treatment of mechanical stress-induced inﬂammation.
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Introduction
　Osteoarthritis （OA） is an age-related degenerative disease that affects various joints of the 
whole body, including knee and hip joints.  In this disease, synovitis occurs at an early stage 
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and the cartilage is worn out by mechanical stress over time.  In Japan, the incidence of this 
disease is increasing as the elderly population increases.  Hence, it is a common disease in 
orthopedic clinics.  A joint is covered with a capsule lined by a synovial membrane, and the 
joint space surrounded by the membrane is filled with synovial fluid.  Additionally, the epiphysis 
is covered with articular cartilage, which is composed of chondrocytes and extracellular matrix 
（ECM）.  However, the cellular component is limited, and the ECM constitutes approximately 
95％ of the cartilage.  The ECM is mainly composed of proteoglycan, collagen, and hyaluronic 
acid with embedded water molecules1）.  Nerves, blood vessels, and lymph vessels do not exist 
in the cartilage ; therefore, when cracks or partial damage occurs, nutrients are not transported 
effectively to cells at the injured site.  Consequently, natural restoration of cartilage is difficult2）.
　In OA, degeneration of cartilage, abrasion of subchondral bone, production of matrix 
metalloproteinase （MMP） and synovial inflammation are induced by mechanical stress （MS） 
resulting from obesity, trauma, and the composition of the cartilage3-5）.  It is a complicated 
condition in which the disease state is influenced by factors such as aging, MS, cartilage 
hypertrophy, cytokines, and genetic predisposition.  
　In this disease, activated T cells invade the synovial membrane and produce cytokines, 
including interleukin （IL）-17, and cause synovitis.  In the proliferated synovium, inflammatory 
cytokines, such as tumor necrosis factor-α （TNF-α）, IL-1, and IL-6 are produced, and receptor 
activator of nuclear factor-κB （NF-κB） ligand is induced, together with IL-17, to activate 
osteoclasts6）.  This mechanism results in the formation of a granulation tissue called pannus, 
which include macrophages and osteoclasts as its cellular components, resulting in substrate 
degradation and bone resorption by proteolytic enzymes such as MMP-37，8）.
　Anti-inflammatory analgesics are used to alleviate pain and inflammation in OA.  Some 
studies have reported in vitro experiments that examined changes in various cytokines and 
inflammatory markers, using IL-1β as an inflammatory substance9）.  However, to the best of our 
knowledge, there has been no report of MS-induced inflammation in cell lines, even though MS 
is essential for the clinical condition of OA.  Therefore, we developed an MS-induced model 
of arthritis that simulates fine bone fragments and motion in a human synovial sarcoma cell 
line （SW982）10）.  In the present study, we compared the effects of various anti-inflammatory 
analgesics at the cellular level.
Materials and methods
Materials and cell culture
　We purchased the human synovial sarcoma cell line, SW98211）, from the American Type 
Culture Collection （Manassas, VA, USA）.  The SW982 cells were cultured in Dulbecco’s 
modified Eagle medium high glucose （FUJIFILM Wako Pure Chemical Corp., Osaka, Japan） 
containing 10％ fetal bovine serum （Sigma Aldrich Co., Tokyo, Japan） under humidified 
conditions at 37°C, with 5％ CO2.  The following reagents were purchased from FUJIFILM 
Wako Pure Chemical Corp. : acetaminophen （50 µM ; 015-13942）, ketoprofen （50 µM ; 115-00381）, 
triamcinolone acetonide （10 µM ; 209-10961） and celecoxib （10 µM ; 032-24841）.  Neurotrophin 
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（3.6 × 10-3 neurtrophin unit（N.U.）） injection solution （3.6 N.U. ;  874420） was purchased from 
Nippon Organ Pharmaceutical Co. Ltd., Osaka, Japan.
MS exposure
　SW982 cells were cultured in a CO2 incubator for 48 hr and exposed to two kinds of stress. 
First, stress was induced by the addition of 5 µg/ml hydroxyapatite in the form of Micro-SHAp 
（IHM-10010 ; Sofsera Co., Ltd., Tokyo, Japan） to mimic the effect of foreign bodies in the joint 
（bone destruction）.  Second, mechanical load stress was induced by shaking the microplates on 
a mini-shaker （PSU-2T ; Funakoshi Co., Ltd., Tokyo, Japan） at 2 mm amplitude and 1,000 rpm as 
described previously10）.
Cell culture
　Cells were seeded at a density of 3 × 104 or 3 × 105 cells/ml and cultured for 24 hr in 6-well 
plates.  The medium was replaced with either standard culture medium or medium containing 
various anti-inflammatory analgesics, and the cells were cultured for a further 48 hr under MS 
conditions.
Evaluation of integrin α5β1 expression by fluorescence immunocytochemical staining
　To evaluate integrin α5β1 receptor expression, cells were adjusted to 1 × 104 cells/ml following 
MS exposure for 48 hr and reacted with anti-integrin alpha V＋beta1 antibody （bs-2016R ; 
Bioss Antibodies Inc., Woburn, MA, USA） at room temperature for 2 hr.  The mixture was 
then reacted with secondary （TRITC-conjugated anti-rabbit IgG ; A 21428 ; Life Technologies, 
Carlsbad, CA, USA） and nuclear-staining antibodies （bisBenzimide H33342 ; FUJIFILM Wako 
Pure Chemical Corporation） for 1 hr, subjected to fluorescence immunocytochemical staining, and 
analyzed using a microscope （BZ-X700 : Keyence, Osaka, Japan）.
Measurement of phospho NF-κB / total NF-κB ratios
　Cells were seeded at a density of 3 × 104 cells/ml in a 6-well plate and cultured for 24 hr. 
The culture medium was replaced with a medium containing anti-inflammatory analgesics, and 
cells were subjected to MS for 48 hr.  Following this, NF-κB p65 （Phospho / Total） was analyzed 
in the cell lysate using the Instant One ELISA Kit （Thermo-Fisher Scientific Co., Ltd., Tokyo, 
Japan）.  Absorbance was measured at 450 nm in a microplate reader.
Measurements of NF-κB, TNF-α, MMP-3, and prostaglandin E2 （PGE2） production
　Cells were seeded at a density of 3 × 104 cells/ml in a 6-well plate and cultured for 24 hr. 
The culture medium was replaced with medium containing each of the anti-inflammatory 
analgesics, and cells were subjected to MS for 48 hr.  The amount of NF-κB p65 （Phospho /
Total）, TNF-α, MPP-3, and PGE2 protein in the culture supernatants was determined using 
the Quantikine ELISA kit （R&D Systems, Minneapolis, MN, USA） and by measuring the 
absorbance at 450 nm in a microplate reader.
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Statistics
　Experimental results are expressed as the mean ± standard error for n＝ 7-16.  The luminance 
in the immunocytochemical staining was analyzed using t-tests, and the data for the MS and 
non-MS groups were analyzed using an ANOVA-Dunnett multiple comparison test.  Values of P
＜ 0.05 were considered significant.
Results
Immunocytochemical staining of integrin α5β1 fluorescence following MS exposure
　Quantification of α5β1 protein expression in SW982 cells by area of luminance revealed that 
the expression of α5β1 protein was significantly higher in the MS group （91.6 ± 6.6 µm2 ; n＝
10） than in the non-MS group （39.8 ± 9.1 µm2 ; n＝ 10 ; P＜ 0.01 ; Fig. 1）.
Effect of anti-inflammatory analgesics on MS-induced NF-κB ratios
　The activation of transcription factor, NF-κB, induces various inflammatory factors following 
exposure of SW982 cells to MS and anti-inflammatory analgesics for 48 hr, indicated by the ratio 
of phosphorylated NF-κB to total NF-κB （Fig. 2）.  The ratio of phosphorylated NF-κB to total 
NF-κB in the MS group （0.937 ± 0.078 ; n＝ 7） was higher than in the non-MS group （0.514 ±
0.045 ; n＝ 9 ; P＜ 0.01）.  In the celecoxib-treated group, a significant suppression in the ratio 
was observed （0.562 ± 0.093 ; n＝ 8）, compared to the MS group （P＜ 0.01）.  However, while 
Fig. 1.   Effect of mechanical stress exposure on integrin α5β1 protein expression. Fluorescence 
immunocytochemical staining of human synovial sarcoma （SW982） cells. Mechanical 
stress for 48 hr （shake）vs. no mechanical stress （control）. Data in histogram represent 
the mean ± standard error （n＝ 10）; t test, ＊＊P＜ 0.01.
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suppression was also induced by the other drugs, it was found to be not significant.
Effect of anti-inflammatory analgesics on MS-induced TNF-α level 
　Figure 3 shows the levels of the inflammatory cytokine, TNF-α, is one of the most rapidly 
secreted in inflammation and powerful biological response mediators, in the medium after 
exposure of SW982 cells to MS and anti-inflammatory analgesics for 48 hr.  The level of TNF-α 
was significantly increased in the MS group （5.140 ± 0.521 pg/ml ; n＝ 12） compared to the non-
MS group （2.534 ± 0.245 pg/ml ; n＝ 13 ; P＜ 0.01）.  In the acetaminophen- （2.445 ± 0.407 pg/ml ; 
n＝ 12）, triamcinolone acetonide- （1,593 ± 0.284 pg/ml ; n＝ 13）, and neurotrophin-treated （2.454
± 0.507 pg/ml ; n＝ 12） groups, this MS-induced increase was significantly suppressed （P＜ 0.05, 
P＜ 0.01 and P＜ 0.05, respectively）.  Conversely, the concentration of TNF-α was significantly 
increased in the celecoxib-treated group （9.434 ± 1.680 pg/ml ; n＝ 10 ; P＜ 0.01 vs. MS）.
Effect of anti-inflammatory analgesics on MS-induced MMP-3 level
　Figure 4 shows the amount of MMP-3 product, a marker of joint destruction, in the culture 
medium following exposure of SW982 cells to MS and anti-inflammatory analgesics for 48 hr. 
There was a significant increase in the MMP-3 level in the MS group （9.210 ± 1.402 pg/ml ; 
n＝ 12） compared to the non-MS group （3.767 ± 0.144 pg/ml ; n＝ 14 ; P ＜ 0.01）.  In the 
acetaminophen- （3.503 ± 0.390 pg/ml ; n＝ 9）, triamcinolone acetonide- （2.703 ± 0.292 pg/ml ; n＝ 9）, 
and neurotrophin-treated （3.921 ± 0.547 pg/ml ; n＝ 9） groups, significant suppression of MMP-3 
expression was observed, compared to MS alone （P＜ 0.01 for all）.
Fig. 2.   Effect of anti-inflammatory analgesics on MS-induced NF-κB activation. SW982 cells （3 ×
104 cells） were cultured in 6-well plates for 24 hr followed by exposure to 48 hr of MS in 
the absence or presence of each anti-inflammatory analgesic. Cell lysates were analyzed by 
the Instant One ELISA kit to determine the ratios of phosphorylated NF-κB p65 to total 
NF-κB p65. Data are expressed as pg/ml and represent the mean ± standard error （n＝ 7-
14）; ＊＊P＜ 0.01, ##P＜ 0.01 vs. MS. MS, mechanical stress ; NF-κB, nuclear factor kappa B ; 
SW982, human synovial sarcoma cell line ; AAP, acetaminophen ; KET, ketoprofen ; CBX, 
celecoxib ; TA, triamcinolone acetonide ; NTP, neurotrophin.
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Estimation of PGE2 production after MS loading
　Figure 5 shows PGE2 production, which is pain-related, after SW982 cells were exposed to MS 
and anti-inflammatory analgesics for 48 hr.  PGE2 concentration in the medium was significantly 
increased by MS （MS, 2732.41 ± 123.57 pg/ml ; non-MS, 1712.10 ± 212.56 pg/ml ; n＝ 12, 9 ; P ＜
0.01）, and significantly decreased after MS by treatment with acetaminophen （1871.22 ± 327.97 pg/
ml ; n＝ 12 ; P ＜ 0.01）, ketoprofen （264.67 ± 29.79 pg/ml ; n＝ 12 ; P ＜ 0.01）, and celecoxib 
（291.28 ± 40.61 pg/ml ; n＝ 12 ; P＜ 0.01）.
Fig. 4.   Effect of anti-inflammatory analgesics on MS-induced MMP-3 level. SW982 cells （3×104 cells） 
were cultured in 6-well plates for 24 hr followed by exposure to 48 hr of MS in the absence 
or presence of each anti-inflammatory analgesic. Supernatants were analyzed by ELISA using 
the Quantikine ELISA kit. Data are expressed as pg/ml and represent the mean ± standard 
error （n＝ 8-14）; ＊＊P ＜ 0.01, ##P ＜ 0.01 vs. MS. MS, mechanical stress ; MMP-3, matrix 
metalloproteinase-3 ; SW982, human synovial sarcoma cell line ; AAP, acetaminophen ; KET, 
ketoprofen ; CBX, celecoxib ; TA, triamcinolone acetonide ; NTP, neurotrophin.
Fig. 3.   Effect of anti-inflammatory analgesics on MS-induced TNF-α level. SW982 cells （3×104 cells） 
were cultured in 6-well plates for 24 hr followed by exposure to 48 hr of MS in the absence 
or presence of each anti-inflammatory analgesic. Supernatants were analyzed by ELISA using 
the Quantikine ELISA kit. Data are expressed as pg/ml and represent the mean ± standard 
error （n＝ 9-14）; ＊＊P＜ 0.01, ＊P＜ 0.05, #P＜ 0.05 vs. MS. MS, mechanical stress ; TNF-α, 
tumor necrosis factor alpha ; SW982, human synovial sarcoma cell line ; AAP, acetaminophen ; 
KET, ketoprofen ; CBX, celecoxib ; TA, triamcinolone acetonide ; NTP, neurotrophin.
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Discussion
　OA is a chronic inflammatory disease with a long clinical course.  In 2009, as an extrapolation 
of an epidemiological study in Japan, it was assumed that 25.3 million people aged 40 years 
and older, about one-fourth of the total Japanese population, would be affected by radiographic 
knee OA12）.  It has been reported that chronic inflammation is caused by damage-associated 
molecular patterns, which are biomolecules released from injured tissues and cells13）.  In 
OA, the microscopic debris resulting from the destruction of the cartilage become damage-
associated molecular patterns, and as they accumulate, the friction inside the joint gradually 
increases, ultimately manifesting as chronic inflammation and promoting synovitis and cartilage 
destruction14）.
　The synovium contains various cells, such as osteoclasts, fibroblasts, macrophages, T cells, and 
B cells.  The SW982 cells used in the present study are derived from fibroblasts and have been 
reported to be useful for analyses involving inflammatory cytokines and MMPs15）.  Integrin α5β1 
is a membrane receptor protein that binds to the ECM and fibronectin and is expressed in the 
synovium16，17）.
　In the physiological state, articular cartilage is an avascular tissue, i.e., even under normal 
conditions it is in a low oxygen state compared to most other tissues18）.  Oxygen partial pressure 
may further decrease due to MS or increased O2 consumption caused by inflammation.  It is 
known that hypoxia-inducible factor-1α, activated by hypoxia, induces the expression of vascular 
endothelial growth factor and other vascular growth factors19）.
　Fibronectin is proteolyzed by MMP-3 and binds to integrin α5β1 on the cell surface, thereby 
activating tyrosine kinases such as integrin-linked kinase and focal adhesion kinase in cells. 
Fig. 5.   Estimation of PGE2 production after MS loading. SW982 cells （3×104 cells） were cultured 
in 6-well plates for 24 hr followed by exposure to 48 hr of MS in the absence or presence 
of each anti-inflammatory analgesic. Supernatants were analyzed by ELISA using the 
Quantikine ELISA kit. Data are expressed as pg/ml and represent the mean±standard error 
（n＝ 9-16）; ＊＊P＜ 0.01, ##P＜ 0.01 vs. MS. MS, mechanical stress ; PGE2, prostaglandin E2 ; 
SW982, human synovial sarcoma cell line ; AAP, acetaminophen ; KET, ketoprofen ; CBX, 
celecoxib ; TA, triamcinolone acetonide ; NTP, neurotrophin.
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Fibronectin is therefore involved in cell proliferation, differentiation, and neovascularization in OA20）.
　Thus, it is possible that activation of the integrin receptors on the cell membrane by MS triggers 
inflammation-induced signal transduction through NF-κB, thereby enhancing TNF-α production 
and inducing MMP-3.  TNF-α further increases inflammation by binding to TNF receptors on 
the cell membrane.  Furthermore, it is thought that MS activates the arachidonic acid cascade 
by modulating the conformation of membrane phospholipids to increase the accessibility of 
phospholipase A2 to its substrate phospholipids and promotes the production of PGE2.
　The antipyretic analgesic, acetaminophen, activates the descending pain modulatory system.  It 
has both an analgesic effect and a weak cyclooxygenase （COX） antagonism, but the detailed 
mechanism remains unknown21）.  In clinical practice, the use of acetaminophen is relatively 
safe for elderly patients, who often have prescriptions for multiple drugs to treat lifestyle-
related diseases and cardiovascular diseases.  Ketoprofen and celecoxib, which are non-
steroidal anti-inflammatory drugs （NSAIDs）, inhibit the activity of COX and synthesis of PGs 
（especially PGE2, which is an agent for enhancing inflammation and pain） in the arachidonic 
acid cascade22）.  They are known to exhibit analgesic, antipyretic, and anti-inflammatory effects. 
Ketoprofen is mainly used in pain relief topical patches in Japan, and its effectiveness has 
been clinically evaluated23）.  Celecoxib demonstrates COX-2 selective inhibitory activity when 
administered orally and possesses the advantage of reducing gastrointestinal disturbances that 
may occur as a side effect of NSAIDs.  Triamcinolone acetonide, a corticosteroid, inhibits the 
activation of mitogen-activated protein kinase and suppresses the activation of phospholipase 
A2, thereby suppressing the release of arachidonic acid, and the activity of activator protein-1 
and NF-κB.  Moreover, it inhibits the production of COX-2, inducible nitric oxide synthase and 
many other cytokines and chemokines, thus exhibiting strong anti-inflammatory properties24-26）. 
The analgesic adjuvant （biological tissue extract） neurotrophin is a non-opioid, non-COX 
inhibiting, descending pain inhibitory system-activated pain therapeutic agent.  Its mechanism of 
action has not yet been elucidated, but it is also effective against pain, such as neuralgia, and is 
used clinically in Japan27）.
　The MS-induced inflammatory state of SW982 resembles the inflammatory state in human 
joints.  Therefore, in this study, we compared the effects of five kinds of clinical anti-
inflammatory analgesics on MS-induced inflammation in SW982 cells.  We found that the 
transcription factor, NF-κB, was significantly suppressed only by celecoxib treatment.  This finding 
can be explained by the fact that transcription factors other than NF-κB, for example, CCAAT-
enhancer-binding protein β, are involved in the anti-inflammatory mechanism of other drugs.  In 
chondrocytes of OA, substrate degradation is thought to occur by various cytokines, including 
IL-1β and TNF-α28）.  Some reports indicate that the expression of inflammatory cytokines and 
substrate-degrading enzymes is induced by excessive MS on chondrocytes3，29）.  CCAAT-enhancer-
binding protein β is induced by stimulation of inflammatory signals such as IL-1b and TNF-α ; 
moreover, it triggers the expression of MMP-1, -3, -13, vascular endothelial growth factor, and 
receptor activator of NF-κB ligand, among others.  As it is a transcription factor, it participates 
in various pathological processes, including inflammation, enhancement of substrate-degrading 
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enzymes, suppression of cartilage matrix protein, and hypertrophy of osteocytes30）.
　In contrast to our observed results with NF-κB, the inflammatory cytokine, TNF-α, and the 
joint destruction marker, MMP-3, were significantly suppressed by acetaminophen, triamcinolone 
acetonide, and neurotrophin treatment.  PGE2 was significantly inhibited in the acetaminophen, 
ketoprofen, and celecoxib treatment groups.  As expected, celecoxib exhibited a potent analgesic 
activity, and it strongly inhibited PGE2.  However, TNF-α responded to celecoxib in an opposite 
manner to the other drugs.  Therefore, we cannot exclude the possibility that celecoxib has an 
inflammation-spreading effect per se.  Based on the above findings, and the data in Table 1, 
NSAIDs have robust analgesic effects, but weak anti-inflammatory and joint destruction 
suppression properties.  Conversely, triamcinolone acetonide and neurotrophin exert a weak 
analgesic effect via PGE2 suppression, but their anti-inflammatory and joint destruction inhibitory 
effects are considered reliable.  Our results indicate that acetaminophen significantly inhibited 
markers of pain, inflammation, and joint destruction in a well-balanced manner.  This suggests 
the possibility that acetaminophen could be useful for relieving arthritis symptoms in OA.
　According to the evidence-based expert consensus guidelines formulated in 2012 by the 
Osteoarthritis Research Society International, it is strongly recommended that treatment of 
knee OA involves a combination of drug and non-drug therapy.  For non-drug therapy, several 
approaches, including gait, muscle strengthening, joint range exercise training, and weight loss, are 
supported by strong evidence and should, therefore, be encouraged31-33）.  However, if the patient 
exhibits pain, non-drug therapy cannot be carried out to the required degree.  The muscular 
strength of the patient reduces, causing a burden on the joint and subsequent inflammation, 
leading to further pain in a vicious cycle.
　Therefore, pain management is critical and is treated with acetaminophen, NSAIDs, and similar 
drug therapies.  Each drug, having its advantages and disadvantages, is selected according to the 
experience of the prescribing physician.  For pain and inflammation, the guideline recommends 
using anti-inflammatory analgesics for OA patients.
　As indicated previously, while NSAIDs are recommended for OA, their side effects should be 
monitored closely.  In this regard, acetaminophen, another anti-inflammatory analgesic, should be 
used besides NSAIDs.  Acetaminophen is considered a relatively safe drug, and it can generally 
be used for elderly patients.  Dosages of up to 4 g/day are safe and effective as oral medicine, 
Table 1.  Effect of various anti-inﬂammatory analgesics on markers of inﬂammation
TNF-α MMP-3 PGE2
Acetaminophen ↓ ↓↓ ↓↓
Ketoprofen ↓↓
Celecoxib ↑↑ ↓↓
Triamcinolone acetonide ↓↓ ↓↓
Neurotrophin ↓ ↓↓
Signiﬁcant differences are indicated by arrows. For↓↓ or↑↑, P＜ 0.01 ; for↓, P＜ 0.05. PGE2, 
prostaglandin E2 ; TNF-α, tumor necrosis factor alpha ; MMP-3, matrix metalloproteinase-3.
Haruna SHIRAKO, et al60
but caution is required against liver dysfunction, which is dose-dependent.  In contrast, oral 
NSAIDs may cause severe complications including peptic ulcers, gastrointestinal perforation, and 
bleeding31）.  Therefore, in Japan, NSAIDs are often used in pain relief topical patches because 
they have few side effects in this form.  Intra-articular injection of adrenal corticosteroids 
may be used mainly for patients for whom oral medications are not effective, although safety 
data are limited ; hence, four or more treatments in a year are not usually recommended31）. 
For celecoxib, the same analgesic effects as those seen with nonselective NSAIDs, as well 
as alleviation of gastrointestinal disorders, have been observed.  However, there have been 
no studies recommending administration methods, while accounting for adverse events and 
complications34）.  Therefore, due attention is required for the dosage and administration interval 
of celecoxib.  
　The results of the present study suggest that using acetaminophen to suppress inflammation, 
pain, and joint destruction may be effective in alleviating MS-induced inflammation.
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